Skip to main content

Table 5 Treatment outcomes in 139 patients with abdominal tuberculosis

From: Clinical features and outcomes of abdominal tuberculosis in southeastern Korea: 12 years of experience

Characteristic All patients (n = 139) Luminal TB (n = 69) Peritoneal TB (n = 28) Nodal TB (n = 7) Visceral TB (n = 23) Mixed TB (n = 12)
Duration of treatment, days 194.0 (176.0–258.0) 189.0 (175.0–219.0) 200.0 (165.0–258.0) 258.0 (16.0–285.0) 284.0 (178.0–284.0) 245.0 (177.5–349.0)
Side effect 21 (15.2%) 11 (15.9%) 3 (11.1%) 0 (0%) 4 (17.4%) 3 (25.0%)
Drug-induced liver injury 9 (6.5%) 5 (8.7%) 2 (7.1%) 0 (0%) 0 (0%) 1 (8.3%)
Nephrectomy 4 (2.9%) 0 (0%) 0 (0%) 0 (0%) 4 (17.4%) c, f 0 (0%)
First-line anti-TB drug 131 (94.2%) 66 (95.7%) 27 (96.4%) 7 (100%) 20 (87.0%) 11 (91.7%)
Second-line anti-TB drug 8 (5.8%) 3 (4.3%) 1 (3.6%) 0 (0%) 3 (13.0%) 1 (8.3%)
Complete response 117 (84.2%) 62 (89.9%) 22 (78.6%) 3 (42.9%) b, e, h, i 20 (87.0%) 10 (83.3%)
Partial response 1 (0.7%) 0 (0%) 0 (0%) 1 (14.3%) 0 (0%) 0 (0%)
No response 2 (1.4%) 1 (1.4%) 0 (0%) 0 (0%) 1 (4.3%) 0 (0%)
Lost to follow up 12 (8.6%) 4 (5.8%) 5 (17.9%) 0 (0%) 1 (4.3%) 2 (16.7%)
Recurrence 3 (2.2%) 1 (1.4%) 1 (3.6%) 1 (14.3%) 0 (0%) 0 (0%)
Transfer out 3 (2.2%) 1 (1.4%) 0 (0%) 2 (28.6%) 0 (0%) 0 (0%)
Death 2 (1.4%) 1 (1.4%) 0 (0%) 0 (0%) 1 (4.3%) 0 (0%)
  1. Data are presented as the median (interquartile range) for continuous data and percentages for categorical data
  2. a: P < 0.05 Luminal TB vs. Peritoneal TB, b: P < 0.05 Luminal TB vs. Nodal TB, c: P < 0.05 Luminal TB vs. Visceral TB, d: P < 0.05 Luminal TB vs. Mixed TB, e: P < 0.05 Peritoneal TB vs. Nodal TB, f: P < 0.05 Peritoneal TB vs. Visceral TB, g: P < 0.05 Peritoneal TB vs. Mixed TB, h: P < 0.05 Nodal TB vs. Visceral TB, i: P < 0.05 Nodal TB vs. Mixed TB, j: P < 0.05 Visceral TB vs. Mixed TB